Related Experiment Video
Updated: Jun 11, 2025
Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
Published on: May 20, 2015
Small molecule Mcl-1 inhibitor for triple negative breast cancer therapy
Shengli Dong1, Suresh K Alahari2,3
1TYK Medicines, Inc., Zhejiang, China.
Abstract:
Apoptosis is an evolutionarily conserved cell death pathway that plays a crucial role in maintaining tissue homeostasis, orchestrating organismal development, and eliminating damaged cells. Dysregulation of apoptosis can contribute to the pathogenesis of malignant tumors and neurodegenerative diseases. Anticancer drugs typically possess the capacity to induce apoptosis in tumor cells. The Bcl-2 protein family, consisting of 27 members in humans, serves as the key regulator of mitochondrial function. This family can be divided into two functional groups: anti-apoptotic proteins (e.g., Bcl-2, Bcl-xl, Mcl-1) and pro-apoptotic proteins (e.g., Bad, Bax). Mcl-1 exerts its function by binding pro-apoptotic Bcl-2 proteins thereby preventing apoptosis induction. Overexpression of Mcl-1 not only correlates closely with tumorigenesis but also associates significantly with resistance towards targeted therapy and conventional chemotherapy. Effective induction of apoptosis can be achieved through inhibition or interference with Mcl-1. Thus, this mini review discusses existing Mcl-1 inhibitors.
Insights
Mcl-1 protein overexpression drives cancer and therapy resistance. Inhibiting Mcl-1 is a promising strategy to induce apoptosis and improve cancer treatment outcomes.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Apoptosis, a programmed cell death pathway, is vital for tissue homeostasis and development.
- Dysregulation of apoptosis is implicated in cancer and neurodegenerative diseases.
- The Bcl-2 protein family regulates mitochondrial apoptosis, with Mcl-1 being a key anti-apoptotic member.
Purpose of the Study:
- To review existing inhibitors targeting Mcl-1.
- To highlight Mcl-1's role in tumorigenesis and therapeutic resistance.
- To discuss strategies for inducing apoptosis via Mcl-1 interference.
Main Methods:
- Literature review of scientific articles on Mcl-1 inhibitors and apoptosis.
- Analysis of Mcl-1's function within the Bcl-2 protein family.
- Discussion of Mcl-1's correlation with cancer progression and treatment resistance.
Main Results:
- Mcl-1 overexpression is linked to cancer development and resistance to therapies.
- Mcl-1 inhibits apoptosis by binding to pro-apoptotic proteins.
- Targeting Mcl-1 offers a pathway to induce cancer cell death.
Conclusions:
- Mcl-1 is a critical target for overcoming cancer therapy resistance.
- Inhibiting Mcl-1 can effectively restore apoptosis in cancer cells.
- Further development of Mcl-1 inhibitors holds significant therapeutic potential.
